Aoyagi, T., Wada, T., Nagai, M., Kojima, F., Harada, S., Takeuchi, T., Takahashi, T., Hirokawa, K. and Tsumita, T. (1990)
Deficiency of kallikrein-like enzyme activities in cerebral tissue
of patients with Alzheimer's disease. Experentia 46: 94–97.
Austin, C. E., Foreman, J. C. and Scadding, G. K. (1994) Reduction by HOE-140, the B2 receptor antagonist, of antigeninduced nasal blockage. Br. J. Pharmacol. 111: 969–971.
Banati, R. B. and Graeber, M. B. (1994) Surveillance, intervention and cytotoxicity: is there a protective role of microglia?
Dev. Neurosci. 16: 114–127.
Banati, R. B., Gehrmann, J., Czech, C., Monning, U., Jones,
L. L., Konig, G., Beyreuther, K. and Kreutzberg, G. W. (1993a)
Early and rapid de novo synthesis of Alzheimer beta A4-amyloid precursor protein (APP) in activated microglia. Glia 9:
199–210.
Banati, R. B., Gehrmann, J., Schubert, P. and Kreutzberg, G. W.
(1993b) Cytotoxicity of microglia. Glia 7: 111–118.
Banati, R. B., Rothe, G., Valet, G. and Kreutzberg, G. W. (1993c)
Detection of lysosomal cysteine proteinases in microglia: flow
cytometric measurement and histochemical localization of
cathepsin B and L. Glia 7: 183–191.
Banati, R. B., Gehrmann, J., Lannes-Vieira, J., Wekerle, H. and
Kreutzberg, G. W. (1995a) Inflammatory reaction in experimental autoimmune encephalomyelitis (EAE) is accompanied
by a microglial expression of the beta A4-amyloid precursor
protein (APP). Glia 14: 209–215.
Banati, R. B., Gehrmann, J., Wiessner, C., Hossmann, K. A. and
Kreutzberg, G. W. (1995b) Glial expression of the beta-amyloid
precursor protein (APP) in global ischemia. J. Cereb. Blood
Flow Metab. 15: 647-654.
Bascands, J. L., Pecher, C., Rouaud, S., Emond, C., Leung, T. J.,
Bastie, M. J., Burch, R., Regoli, D. and Girolami, J. P. (1993)
Evidence for existence of two distinct bradykinin receptors on
rat mesangial cells. Am. J. Physiol. 264: F548–F556.
Benarroch, E. E. (1994) Neuropeptides in the sympathetic system:
presence, plasticity, modulation, and implications. Ann. Neurol. 36: 6–13.
Bernard, T., Brisson, J., Côtè, C., Brisson, S., Potvin, D. and Roberge, N. (1993) Prognostic significance of cathepsin-D expression
in node-positive breast carcinoma: an immunohistochemical
study. Int. J. Cancer 55: 429–435.
Betz, A. L. (1992) An overview of the multiple functions of the
blood brain barrier. In: Bioavailability of Drugs to the Brain and
the BBB, pp. 54–72, Frankenheim, J. and Brown, R. (eds.)
Rockville.
Bhattacharya, S. K., Rao, P. J., Brumleve, S. J. and Parmar, S. S.
(1986) Effects of intracerebroventricular administration of
bradykinin on rat brain serotonin and prostaglandins. Res.
Commun. Chem. Pathol. Pharmacol. 54: 355–366.
Bhoola, K. D. and Lauar, N. (1986) Release of tissue kallikrein
from the isolated perfused rat kidney. Adv. Exp. Med. Biol. 198:
347–354.
Bhoola, K. D., Evans, R. H. and Forster, M. R. (1987) Excitatory
effect of bradykinin on spinal neurones. Br. J. Pharmacol. 90:
15P .
Bhoola, K. D., Figueroa, C. D. and Worthy, K. (1992) Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev. 44: 1–80.
Bult, H., Boeckxstaens, G. E., Pelckmans, P. A., Jordaens, F. H.,
Van Maercke, Y. M. and Herman, A. G. (1990) Nitric oxide as
an inhibitory non-adrenergic non-cholinergic neurotransmitter. Nature 345: 346–347.
